Clinical Trials Browser

Phase 2 × NETWORK × samarium Sm-153 lexidronam × Clear all

NCT00551525 2017-07-25

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Phase 2 Completed

67 enrolled 10 charts

Prostatic Neoplasms